Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring.

Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the …

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives.

1 天前 · Edwards Lifesciences (NYSE:EW) traded higher on Thursday after Stifel upgraded the heart device maker to Buy from Hold, citing a turnaround in its position in the market for …

23 小时之前 · Edwards Lifesciences Corporation EW is expected to report fourth-quarter 2024 results shortly.. See the Zacks Earnings Calendar to stay ahead of market-making news.. In …

2024年12月4日 · NEW YORK--(BUSINESS WIRE)-- Edwards Lifesciences Corporation (NYSE: EW) will discuss the company’s focused strategy for long-term sustainable growth, provide an …

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence …

3 天之前 · Company announces $1 billion share repurchase Edwards Lifesciences (NYSE: EW) has successfully completed the sale of its Critical Care product group to BD (Becton, …

Global leader in the medical device industry with a patient-focused culture of innovation | Edwards Lifesciences (NYSE: EW), is the leading global structural heart innovation company, driven by...

2024年3月11日 · Edwards Lifesciences (NYSE: EW) announced today at Cardiovascular Research Technologies (CRT) 2024 the compelling results from two large, real-world studies …